|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
|
TWI436991B
(zh)
|
2004-11-22 |
2014-05-11 |
歐 賽提克股份有限公司 |
用於純化反-（-）-△９-四氫大麻酚與反-（＋）-△９-四氫大麻酚之方法
|
|
US8628796B2
(en)
*
|
2004-12-09 |
2014-01-14 |
Insys Therapeutics, Inc. |
Room-temperature stable dronabinol formulations
|
|
KR100753959B1
(ko)
*
|
2006-01-12 |
2007-08-31 |
에이펫(주) |
기판 건조장치를 이용한 기판 건조방법
|
|
CA2657332A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Wine, Harvey |
Transdermal formulations of synthetic cannabinoids and nano colloidal silica
|
|
US20080069871A1
(en)
*
|
2006-07-21 |
2008-03-20 |
Vaughn Jason M |
Hydrophobic abuse deterrent delivery system
|
|
WO2008019146A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
US8039509B2
(en)
*
|
2006-11-10 |
2011-10-18 |
Johnson Matthey Public Limited Company |
Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
|
|
US8980940B2
(en)
|
2006-11-10 |
2015-03-17 |
Johnson Matthey Public Limited Company |
Stable cannabinoid compositions and methods for making and storing them
|
|
DK2176208T3
(en)
*
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
CA2698752A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
JP5570996B2
(ja)
|
2007-12-14 |
2014-08-13 |
エアロデザインズ インコーポレイテッド |
エアロゾル化可能な食料品の送達
|
|
GB0807915D0
(en)
*
|
2008-05-01 |
2008-06-04 |
Resolution Chemicals Ltd |
Production of delta 9 tetrahydrocannabinol
|
|
BRPI1014139A2
(pt)
*
|
2009-06-29 |
2016-04-26 |
Bender Analytical Holding Bv |
sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
AU2011252039B2
(en)
|
2010-05-10 |
2014-06-12 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
|
CN103002881B
(zh)
|
2010-05-10 |
2015-09-02 |
欧洲凯尔特公司 |
载有活性剂的颗粒与额外活性剂的组合
|
|
CA2798884C
(en)
|
2010-05-10 |
2016-09-13 |
Euro-Celtique S.A. |
Manufacturing of active-free granules and tablets comprising the same
|
|
US8629177B2
(en)
*
|
2010-08-24 |
2014-01-14 |
Aphios Corporation |
Nanoencapsulated delta-9-tetrahydrocannabinol
|
|
US8703727B2
(en)
*
|
2010-08-24 |
2014-04-22 |
Aphios Corporation |
Nanotechnology formulation of poorly soluble compounds
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
WO2012148432A1
(en)
|
2011-04-28 |
2012-11-01 |
Acme Specialty Products, Llc |
Taste masking compositions and edible forms thereof
|
|
US8758826B2
(en)
*
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
WO2013147965A1
(en)
*
|
2012-03-28 |
2013-10-03 |
Freeman Keith Gerald |
Medical compositions, methods of making and using those compositions, and kits including those compositions
|
|
EP2897632A4
(en)
*
|
2012-05-30 |
2016-10-12 |
Univ Andres Bello |
COMPOUNDS FOR MODULATING THE ASTROCYTIC RELEASE OF SUBSTANCES BY CONNEXINE AND PANNEXINE AND TREATMENT OF PSYCHIATRIC DISEASES
|
|
US12496271B2
(en)
|
2019-02-22 |
2025-12-16 |
Benuvia Operations, Llc |
Oral cannabinoid formulations
|
|
US10265293B2
(en)
|
2012-10-04 |
2019-04-23 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
US11253472B2
(en)
|
2012-10-04 |
2022-02-22 |
Benuvia Therapeutics Llc |
Oral cannabinoid formulations
|
|
US9345771B2
(en)
|
2012-10-04 |
2016-05-24 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
KR20190139327A
(ko)
|
2013-02-12 |
2019-12-17 |
코버스 파마수티컬스, 아이엔씨. |
초고순도 테트라하이드로카나비놀-11-오익산
|
|
HK1218720A1
(zh)
|
2013-04-30 |
2017-03-10 |
欧缇托匹克公司 |
干粉制剂及使用方法
|
|
AU2014340709B2
(en)
|
2013-10-29 |
2019-07-04 |
Echo Pharmaceuticals B.V. |
Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders
|
|
CN105873566B
(zh)
|
2013-10-29 |
2019-06-07 |
艾克制药有限公司 |
含有δ9-四氢大麻酚的压制片剂、其制造方法及此类片剂在口服治疗中的用途
|
|
WO2015071380A1
(en)
|
2013-11-13 |
2015-05-21 |
Euro-Celtique S.A. |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
|
|
WO2015106108A2
(en)
*
|
2014-01-13 |
2015-07-16 |
Kannalife, Inc. |
Novel functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
US10610512B2
(en)
|
2014-06-26 |
2020-04-07 |
Island Breeze Systems Ca, Llc |
MDI related products and methods of use
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
CN107075523B
(zh)
*
|
2014-06-27 |
2022-04-19 |
加拿大国家研究委员会 |
来自大麻的大麻环萜酚酸合酶
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20160143972A1
(en)
*
|
2014-11-21 |
2016-05-26 |
Cannamark Inc. |
Method and apparatus for preparing a solid form of cannabinoid
|
|
EP3268043A4
(en)
*
|
2015-03-10 |
2018-12-19 |
Nanosphere Health Sciences, LLC |
Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
AU2016326626A1
(en)
*
|
2015-09-24 |
2018-04-26 |
Pasenture, Inc. |
Cannabinoid compositions and methods of making
|
|
EP3253375B1
(en)
|
2016-02-11 |
2019-04-10 |
Gelpell AG |
Oral solid cannabinoid formulations, methods for producing and using thereof
|
|
US10542770B2
(en)
|
2016-03-18 |
2020-01-28 |
Aceso Wellness LLC |
Cannabinoid emulsion product and process for making the same
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
EP3928776B1
(en)
|
2016-04-22 |
2025-11-12 |
Spoke Sciences, Inc. |
Fast-acting plant-based medicinal compounds and nutritional supplements
|
|
JP2019518760A
(ja)
*
|
2016-06-15 |
2019-07-04 |
オーハイ エナジェティクス ピービーシー |
幹細胞療法を増強するための方法および組成物
|
|
DK3474844T3
(da)
|
2016-06-28 |
2022-08-29 |
Trichomeshell Ltd |
Doseringsform til fordampning og rygning
|
|
US9717683B1
(en)
|
2016-06-29 |
2017-08-01 |
Ep Pharma, Llc |
Low-temperature inhalation administration of cannabinoid entities
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
EA201892396A1
(ru)
*
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
US20190224117A1
(en)
*
|
2017-06-14 |
2019-07-25 |
Yury Leon Shmerlis |
Cannabis Extract Chewing Gum
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
EP3665145A1
(en)
|
2017-08-07 |
2020-06-17 |
Enantia, S.L. |
A cocrystal of 2-[(1r,6r)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
|
|
WO2019045994A1
(en)
*
|
2017-08-27 |
2019-03-07 |
Rhodes Technologies |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
|
|
US10786456B2
(en)
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
KR102681843B1
(ko)
|
2017-09-22 |
2024-07-05 |
벡추라 인코포레이티드 |
스테아르산마그네슘을 갖는 건조 분말 조성물
|
|
US10220061B1
(en)
|
2017-09-26 |
2019-03-05 |
Cynthia Denapoli |
Method of reducing stress and anxiety in equines
|
|
US12582664B2
(en)
|
2017-09-28 |
2026-03-24 |
Harmony Biosciences Management, Inc. |
Treatment of fragile x syndrome with cannabidiol
|
|
ES2907325T3
(es)
|
2017-09-28 |
2022-04-22 |
Zynerba Pharmaceuticals Inc |
Tratamiento de síndrome del cromosoma X frágil y autismo con cannabidiol
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US11179340B2
(en)
*
|
2017-12-29 |
2021-11-23 |
TGC Network LLC |
Cannabidiol dosage form
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
EP3745884A1
(en)
|
2018-01-31 |
2020-12-09 |
Canopy Holdings, Llc |
Hemp powder
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
EP3823598A2
(en)
*
|
2018-07-18 |
2021-05-26 |
Glatt Gmbh |
Immediate release formulations of cannabinoids
|
|
CA3091719A1
(en)
|
2018-08-08 |
2020-02-13 |
Neptune Wellness Solutions Inc. |
Cold extraction method for cannabinoids and terpenes from cannabis by organic solvents
|
|
KR20210116432A
(ko)
*
|
2018-10-10 |
2021-09-27 |
틸레이, 인크. |
화학요법으로 유발된 메스꺼움 및 구토 치료를 위한 방법 및 제형
|
|
CA3119729A1
(en)
|
2018-10-10 |
2020-04-16 |
Treehouse Biotech, Inc. |
Synthesis of cannabigerol
|
|
WO2020089424A1
(en)
|
2018-10-31 |
2020-05-07 |
Enantia, S.L. |
Solid compositions of cocrystals of cannabinoids
|
|
AU2019385420A1
(en)
|
2018-11-19 |
2021-07-08 |
Spoke Sciences, Inc. |
N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
|
|
CA3119037A1
(en)
|
2018-12-11 |
2020-06-18 |
Disruption Labs Inc. |
Compositions for the delivery of therapeutic agents and methods of use and making thereof
|
|
US10959961B2
(en)
|
2018-12-14 |
2021-03-30 |
Natural Extraction Systems, LLC |
Methods of administering anionic cannabinoid molecules dissolved in water
|
|
MX2021007076A
(es)
|
2018-12-14 |
2021-08-11 |
Zynerba Pharmaceuticals Inc |
Tratamiento para el sindrome de supresion del 22q11.2 con cannabidiol.
|
|
EP3893673A4
(en)
*
|
2018-12-14 |
2023-05-03 |
Natural Extraction Systems, LLC |
COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES
|
|
US10609944B1
(en)
|
2018-12-14 |
2020-04-07 |
Natural Extraction Systems, LLC |
Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
|
|
WO2020176526A1
(en)
*
|
2019-02-25 |
2020-09-03 |
Paul Mendell |
Methods for delivering nutritional and therapeutic supplements with food and drug products
|
|
CN112062697B
(zh)
*
|
2019-05-22 |
2023-09-01 |
上海特化医药科技有限公司 |
间苯多酚衍生物及其制备方法
|
|
IL288196B2
(en)
*
|
2019-05-23 |
2025-08-01 |
Kare Chemical Tech Inc |
Catalytic cannabinoid processes and precursors
|
|
WO2020264199A1
(en)
*
|
2019-06-26 |
2020-12-30 |
Natural Extraction Systems, LLC |
Containers, compositions, methods related to cannabinoid anions
|
|
US20220339227A1
(en)
*
|
2019-09-18 |
2022-10-27 |
Board Of Regents, The University Of Texas System |
Compositions of cannabinoids for delivery by inhalation
|
|
US11542243B1
(en)
|
2019-09-26 |
2023-01-03 |
FusionFarms, LLC |
Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
CN114650809A
(zh)
|
2019-10-03 |
2022-06-21 |
斯塔顿治疗公司 |
屈大麻酚的透皮递送
|
|
WO2021071967A1
(en)
*
|
2019-10-09 |
2021-04-15 |
Island Breeze Systems Ca, Llc |
Compositions for pulmonary delivery of cannabinoids and associated methods and systems
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
WO2021072325A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Corbus Pharmaceuticals, Inc. |
Compositions of ajulemic acid and uses thereof
|
|
CA3155176A1
(en)
|
2019-10-11 |
2021-04-15 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal compositions comprising cannabidiol (cbd) for use in the treatment of seizure disorders
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
CA3155181A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
US20220387339A1
(en)
*
|
2019-10-21 |
2022-12-08 |
Esolate Ltd |
Superfine compounds and production thereof
|
|
GB2588456B
(en)
*
|
2019-10-25 |
2023-02-01 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588457B
(en)
*
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588455B
(en)
*
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
WO2021096886A1
(en)
*
|
2019-11-11 |
2021-05-20 |
Natural Extraction Systems, LLC |
Methods to separate cannabinoids from impurities by crystallization
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
WO2021195540A1
(en)
*
|
2020-03-26 |
2021-09-30 |
Radient Technologies Innovations Inc. |
Cannabinoid based composition for mitigation of viral effects
|
|
EP4153306A4
(en)
|
2020-05-22 |
2024-06-26 |
Ilera Derm LLC |
Compositions for treating acne and dermatological conditions
|
|
US12349706B2
(en)
|
2020-07-31 |
2025-07-08 |
Natural Extraction Systems, LLC |
Compositions and methods related to excipients and cannabinoid formulations
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
IL278286B
(en)
|
2020-10-25 |
2021-06-30 |
Fine Can Ltd |
Cannabis powders and their uses
|
|
WO2022115718A1
(en)
*
|
2020-11-29 |
2022-06-02 |
Castor Trevor P |
Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomass
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
US20220317097A1
(en)
*
|
2021-04-05 |
2022-10-06 |
Grant Kraus |
Atmospheric Triphasic Chromatography (ATC) method
|
|
WO2022232574A1
(en)
|
2021-04-29 |
2022-11-03 |
Tilray, Inc. |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
US20220387256A1
(en)
*
|
2021-06-03 |
2022-12-08 |
Kent Byron |
Vial With Metered Dispenser
|
|
WO2023015102A1
(en)
*
|
2021-07-26 |
2023-02-09 |
Rapid Therapeutic Sciences Laboratories, Inc. |
Process for producing cbd isolate
|
|
ES2962999T3
(es)
|
2021-07-30 |
2024-03-22 |
Cannamedical Pharma Gmbh |
Parche transmucoso que comprende un cannabinoide y/o un opiáceo
|
|
WO2024033521A1
(en)
|
2022-08-12 |
2024-02-15 |
GW Research Limited |
Oral solid dosage forms comprising cannabinoids
|
|
CN115784836A
(zh)
*
|
2022-12-08 |
2023-03-14 |
南京康立瑞生物科技有限公司 |
一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法
|
|
WO2024160792A1
(en)
|
2023-01-30 |
2024-08-08 |
Cannamedical Pharma Gmbh |
Improved transmucosal patch comprising a cannabinoid and/or an opioid
|
|
KR102952971B1
(ko)
*
|
2023-06-01 |
2026-04-15 |
충남대학교 산학협력단 |
올리베톨 또는 이의 약제학적으로 허용가능한 염을 유효성분으로 포함하는, 뇌전증 또는 퇴행성 신경질환의 예방 및 치료용 약학 조성물
|
|
WO2025164161A1
(ja)
*
|
2024-01-29 |
2025-08-07 |
シオノギファーマ株式会社 |
カンナビジオールの溶媒和物及びカンナビジオールの精製方法
|
|
US12605394B2
(en)
|
2024-07-25 |
2026-04-21 |
Visionary Assets, Llc |
Compositions containing cannabinoid nanoparticles
|